Non-Hodgkin Lymphoma Subtypes: 2004-2011

Exepected Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population,
UK

Male Female Persons

AS Rate (95% AS Rate (95%
AS Rate (95%
Cases LCL-95% Cases Cases LCL-95%
LCL-95% UCL)
UCL) UCL)
Diffuse large B-Cell Lymphoma 2,532 7.8 (7.6-8) 2199 5.6 (5.4-5.7) 4835 6.6 (6.5-6.7)
Marginal Zone Lymphomas 1,073 3.2 (2.5-2.6) 847 2.0 (1.9-2.1) 1,962 2.5 (2.5-2.6)
Follicular Lymphoma 857 2.7 (2.6-2.8) 998 2.8 (2.7-2.9) 1,884 2.8 (2.7-2.8)
B-cell Mantle Cell Lymphoma 331 1 (0.9-1.1) 181 0.4 (0.3-0.4) 513 0.6 (0.6-0.7)
Burkitt Lymphoma 152 0.5 (0.4-0.6) 52 0.2 (0.1-0.2) 204 0.3 (0.3-0.4)

T-cell Lymphomas 350 1.1 (1-1.2) 254 0.7 (0.6-0.7) 604 0.9 (0.8-0.9)

Lymphoproliferative Disorder Not Otherwise Specified 608 1.8 (1.7-1.9) 509 1.0 (0.9-1.1) 1116 1.3 (1.3-1.4)
95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate
Source: cruk.org/cancerstats
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source.
Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].